Saving muscle while losing weight: A vital strategy for sustainable results while on glucagon-like peptide-1 related drugs. [PDF]
Cigrovski Berkovic M +3 more
europepmc +1 more source
Protocol to generate stem cell-derived alpha cells in 3D suspension culture. [PDF]
Salomon T +3 more
europepmc +1 more source
Glucagon-like peptide-1 receptor agonists and suicide risk in individuals with diabetes and Cannabis use disorder. [PDF]
Dhruva Y, Messias E, Lin PI.
europepmc +1 more source
Patterns and costs associated with glucagon-like peptide-1 receptor agonist use in US adults with type 2 diabetes. [PDF]
Wu J, Perez A, Sullivan PW.
europepmc +1 more source
Severe euglycemic ketoacidosis following combined therapy with GLP-1 receptor agonist and SGLT-2 inhibitor, refractory to standard treatment: a case report. [PDF]
Gandecka-Pempera A +3 more
europepmc +1 more source
CHIP mediates glucagon action on hepatic glucose production via regulating Smad3 ubiquitination. [PDF]
Pan Q +6 more
europepmc +1 more source
GLP-1 Injectable Use Among Adults With Diagnosed Diabetes: United States, 2024.
Vahratian A, Warren A.
europepmc +1 more source
Related searches:
Glucagon is a pancreatic peptide hormone that, as a counterregulatory hormone for insulin, stimulates glucose release by the liver and maintains glucose homeostasis. First described as a glucagon binding entity functionally linked to adenylyl cyclase, the glucagon receptor is a member of the family B receptors within the G protein coupled superfamily ...
Authier, François, Desbuquois, Bernard
openaire +4 more sources
Glucagon and the Glucagon-Like Peptides
Pancreas, 1990Glucagon and the glucagon-like peptides are encoded within a larger precursor, proglucagon. The proglucagon gene is expressed in the pancreas, intestine, and brain, giving rise to a single proglucagon mRNA transcript that is identical in all tissues. Tissue-specific posttranslational processing of proglucagon accounts for the different molecular forms ...
openaire +4 more sources

